Product-first
Opportunities are grounded in products with sell pages, reference deployments or live commercial surfaces — not abstract pitch concepts.
Strategic Growth & Investment
Zi SoftTech develops proprietary software products designed around real business workflows. Selected opportunities are open to strategic investors and partners who can accelerate commercialization, distribution and market expansion.
Product-level opportunities • Strategic capital • Distribution partnerships • Private discussions
Investment thesis
Zi SoftTech builds proprietary products around how real businesses run: national tourism infrastructure, travel operations software, parental-control products, publisher monetization and white-label business systems. Selected growth opportunities are made available where capital or partnership can accelerate commercialization, distribution and market expansion.
Opportunities are grounded in products with sell pages, reference deployments or live commercial surfaces — not abstract pitch concepts.
Not every product is open for investment. Each opportunity is classified by intent: strategic capital, distribution, commercial partnership, or not currently raising.
Detailed commercial materials, forecasts and structuring discussion belong in a private investor brief — not on a public marketing page.
Where capital is not the primary need, Zi SoftTech prioritizes distribution, white-label and market-access partners who strengthen go-to-market.
Strategic partnership pathways
Depending on the product and the counterparty, engagement may take the form of strategic investment, distribution, white-label commercialization or a scoped commercial partnership.
Strategic capital
For selected products where growth capital can accelerate commercialization, distribution or regional expansion. Terms and materials are shared privately after fit is confirmed.
Market access
For counterparties with a country, board or regional mandate — particularly around national tourism infrastructure and related SoftTech surfaces.
White-label
Operate selected SoftTech platforms under your brand where multi-brand and partner console capabilities are already part of the product architecture.
Distribution
Introduce selected SoftTech products through an existing network — agencies, schools, telecoms, travel groups, publishers or regional operators.
Featured product opportunities
Each card states what the product is for, its current stage, how it is commercialized and the strategic objective of any discussion. Only verified qualitative information is shown publicly.
Evidence / product readiness
Opportunity discussions start from real SoftTech surfaces — product pages and portfolio case studies — not from unsupported claims.
What growth capital can accelerate
For products marked as strategic investment opportunities, growth capital is discussed as a means to accelerate commercialization — not as a public funding appeal.
Sales, onboarding and partner enablement for selected product lines.
Reseller, white-label and regional partner coverage.
Country and regional expansion where product fit and mandate align.
Delivery and customer success capacity for serious commercial pipelines.
Specific use-of-funds detail, forecasts and structuring belong in the confidential investor brief.
Who we partner with
Zi SoftTech engages strategic investors and partners who bring capital, distribution, market access or a clear commercial mandate — and who expect institutional diligence.
Evaluating product-level opportunities with proprietary software, clear buyers and private diligence materials.
Telecoms, travel groups, agencies, hosters, schools and distributors seeking white-label or distribution pathways.
Country and regional mandates for tourism infrastructure and related SoftTech deployments.
Parties with brand, territory or distribution strength who need SoftTech product delivery.
Investment process
01
Request the investor brief or a product brief. Indicate whether your interest is capital, distribution or commercial partnership.
02
A short conversation confirms alignment with a selected opportunity — not every inquiry advances.
03
Qualified counterparties receive the Investment & Strategic Partnership Prospectus and relevant product materials under appropriate confidentiality.
04
Product walkthrough, commercial discussion and structuring — shared privately, never as public marketing claims.
FAQ
No. Opportunities are selective. Each product is marked by engagement intent — strategic investment opportunity, distribution partnership, commercial partnership, or not currently raising.
Use Request Investor Brief on this page. After fit is confirmed, qualified counterparties receive confidential materials privately.
No. Public pages do not disclose cap table, valuation, forecasts, shareholding proposals or private financial data. Those belong in the confidential prospectus.
Yes. Distribution and commercial partnerships are first-class pathways for selected products.
Yes. Country and regional deployments can be discussed with parties who bring mandate, market access or strategic capital. Details are handled privately after fit confirmation.
Start with the public portfolio case studies and product pages linked in the Evidence section. Private diligence materials follow after interest and fit are confirmed.
Ready to talk
Still evaluating an investment or strategic partnership?
Book a confidential discussion — qualified counterparties receive materials privately, not on this public page.